Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0069 | 0.9 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |